A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB)

A new chemical testing platform harnesses colour- and light-producing genes from wildlife to speed the search for promising RNA-based therapeutics.

Targeting a key gene can help prevent the body’s immune fighters from wearing out when attacking tumour cells, offering a new treatment strategy against cancer.

The distance between certain cell types in pancreatic tumours can predict whether patients live longer.

SINGA scholar Senuri De Silva merges computational biology with translational science to unlock protein-level insights into the mechanisms of disease.

Integrating molecular insights from several omics profiling approaches, A*STAR research initiatives are deepening our understanding of human physiology and unearthing new diagnostic and therapeutic opportunities.

Scientists dig into tempeh to uncover how microbial action breaks down soybean proteins into smaller, more digestible and more nutritious forms.

This year, the National Research Foundation Singapore is empowering three A*STAR researchers to push the boundaries of science.

A new spatial genomic scoring system outdoes existing tools at identifying patients at risk of recurring liver tumours.

A new study reveals that the genetic defect behind spinal muscular atrophy may also cause long-term liver issues for both patients and carriers.

A new spatial multi-omics tool merges different levels of biological data from the same tissue sample to better differentiate finer details at different health states.

Hormone traces in aquaculture tank water offer a less intrusive way to monitor the health of popular Asian fish farm stocks.

Cell and gene therapies are driving the next revolution in medicine, combining the best of biology with game-changing technologies from A*STAR researchers and partners.